267 related articles for article (PubMed ID: 2030601)
21. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate.
Liliemark JO; Plunkett W
Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676
[TBL] [Abstract][Full Text] [Related]
22. Mechanism for ara-CTP catabolism in human leukemic cells and effect of deaminase inhibitors on this process.
Fridland A; Verhoef V
Semin Oncol; 1987 Jun; 14(2 Suppl 1):262-8. PubMed ID: 3035721
[No Abstract] [Full Text] [Related]
23. Modulation of the effect of 1-beta-D-arabinofuranosylcytosine based on changes of cytidine deaminase activity in HL60 cells.
Mejer JN; Mortensen BT; Christensen IJ
Med Oncol Tumor Pharmacother; 1990; 7(1):25-9. PubMed ID: 2338846
[TBL] [Abstract][Full Text] [Related]
24. Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells.
Bhalla K; Cole J; MacLaughlin W; Arlin Z; Baker M; Graham G; Grant S
Leukemia; 1987 Dec; 1(12):814-9. PubMed ID: 2447450
[TBL] [Abstract][Full Text] [Related]
25. The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.
Mancini WR
Cancer Chemother Pharmacol; 1992; 30(2):139-44. PubMed ID: 1318170
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
Grant S; Turner A; Nelms P; Yanovich S
Leukemia; 1995 May; 9(5):808-14. PubMed ID: 7769843
[TBL] [Abstract][Full Text] [Related]
27. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
Riva CM; Rustum YM
Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
[TBL] [Abstract][Full Text] [Related]
28. Human immunodeficiency virus type 1 induces 1-beta-D-arabinofuranosylcytosine resistance in human H9 cell line.
Yusa K; Oh-hara T; Tsukahara S; Tsuruo T
J Biol Chem; 1992 Aug; 267(24):16848-50. PubMed ID: 1512227
[TBL] [Abstract][Full Text] [Related]
29. Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: interactions with deoxycytidine.
Harris AL; Grahame-Smith DG
Cancer Chemother Pharmacol; 1981; 5(3):185-92. PubMed ID: 6945922
[TBL] [Abstract][Full Text] [Related]
30. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
Ramilo-Torno LV; Avramis VI
Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
[TBL] [Abstract][Full Text] [Related]
31. Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine.
Riccardi R; Chabner B; Glaubiger DL; Wood J; Poplack DG
Cancer Res; 1982 May; 42(5):1736-9. PubMed ID: 6896013
[TBL] [Abstract][Full Text] [Related]
32. Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.
Bhalla K; Grant S
Cancer Chemother Pharmacol; 1987; 19(3):226-32. PubMed ID: 3581416
[TBL] [Abstract][Full Text] [Related]
33. Metabolism and toxicity of electroporated 1-beta-D-arabinofuranosylcytosine triphosphate in a human leukemia cell line.
Kubota M; Yorifuji T; Hashimoto H; Shimizu T; Mikawa H
Jpn J Cancer Res; 1990 Dec; 81(12):1314-9. PubMed ID: 2126001
[TBL] [Abstract][Full Text] [Related]
34. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
Grant S; Bhalla K; Arlin Z; Howe CW
Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
[TBL] [Abstract][Full Text] [Related]
35. Combinations of tetrahydrouridine and cytosine arabinoside in mouse tumors.
Kreis W; Hession C; Soricelli A; Scully K
Cancer Treat Rep; 1977 Oct; 61(7):1355-64. PubMed ID: 589601
[TBL] [Abstract][Full Text] [Related]
36. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ
Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322
[TBL] [Abstract][Full Text] [Related]
37. Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells.
Momparler RL; Onetto-Pothier N; Bouffard DY; Momparler LF
Cancer Chemother Pharmacol; 1990; 27(2):141-6. PubMed ID: 2249330
[TBL] [Abstract][Full Text] [Related]
38. Effect of cell growth and cell differentiation on 1-beta-D-arabinofuranosylcytosine metabolism in myeloid cells.
Chiba P; Tihan T; Eher R; Köller U; Wallner C; Göbl R; Linkesch W
Br J Haematol; 1989 Apr; 71(4):451-5. PubMed ID: 2713269
[TBL] [Abstract][Full Text] [Related]
39. Interaction of deoxycytidine and deoxycytidine analogs in normal and leukemic human myeloid progenitor cells.
Grant S; Bhalla K; Gleyzer M
Leuk Res; 1986; 10(9):1139-46. PubMed ID: 2429121
[TBL] [Abstract][Full Text] [Related]
40. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity.
Tanaka M; Yoshida S
Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
